𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pyrogallol inhibits the growth of human pulmonary adenocarcinoma A549 cells by arresting cell cycle and triggering apoptosis

✍ Scribed by Yong Hwan Han; Suhn Hee Kim; Sung Zoo Kim; Woo Hyun Park


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
126 KB
Volume
23
Category
Article
ISSN
1095-6670

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Pyrogallol (PG) is a polyphenol compound and has been known to be an O generator. We evaluated the effects of PG on the growth of human pulmonary A549 cells in relation to the cell cycle and apoptosis. Treatment with 50 or 100 ΞΌM PG significantly inhibited the cell growth of A549 for 72 h. DNA flow cytometric analysis indicated that PG slightly induced a G1 phase arrest of the cell cycle at 24 or 48 h, but did not induce the specific cell cycle arrest at 72 h. Intracellular GSH depletion was observed in PG‐treated cells. PG induced apoptosis in A549 cells, as evidenced by sub‐G1 cells, annexin V staining cells, and the loss of mitochondrial membrane potential (Ξ” Ξ¨~m~). The intracellular ROS (reactive oxygen species) level including O increased in PG‐treated A549 cells at 24 and 48 h, and persisted at 72 h. The changes in GSH as well as ROS levels by PG affected the cell viability in A549 cells. In conclusion, PG inhibited the growth of human pulmonary A549 cells by inducing cell cycle arrest as well as triggering apoptosis. Β© 2009 Wiley Periodicals, Inc. J Biochem Mol Toxicol 23:36–42, 2009; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/jbt.20263


πŸ“œ SIMILAR VOLUMES


Silibinin inhibits human nonsmall cell l
✍ Samiha Mateen; Alpna Tyagi; Chapla Agarwal; Rana P. Singh; Rajesh Agarwal πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 461 KB

## Abstract Recent studies show that silibinin possesses a strong antineoplastic potential against many cancers; however, its efficacy and underlying molecular mechanisms in nonsmall cell lung cancer (NSCLC) are not well defined. Herein, we assessed silibinin activity on prime endpoints and key mol

Naftopidil, a selective Ξ±-1 adrenoceptor
✍ Hideki Kanda; Kenichiro Ishii; Yuji Ogura; Tetsuya Imamura; Masahiro Kanai; Kimi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 275 KB πŸ‘ 1 views

## Abstract α‐1 adrenoceptor antagonists are generally prescribed for benign prostate hyperplasia with lower urinary tract symptoms. Naftopidil, a selective α‐1 adrenoceptor antagonist, is frequently used in Japan because it has fewer side effects. Here we demonstrate for the first time that naftop

Induction of cell-cycle arrest and apopt
✍ Koji Fujimoto; Ryo Hosotani; Ryuichiro Doi; Michihiko Wada; Jeon-Uk Lee; Takatom πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 142 KB πŸ‘ 2 views

In this study, we investigated the effect of a novel retinobenzoic acid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), on the growth of 4 human pancreatic-cancer cell lines; BxPC-3, MIAPaCa-2, CFPAC-1 and AsPC-1. TAC-101 significantly inhibited the proliferation of BxPC-3 and MIA-Pa